Literature DB >> 26295502

Best Practices in Alemtuzumab Administration: Practical Recommendations for Infusion in Patients With Multiple Sclerosis.

Lynn McEwan1, Christina Caon, Carol Chieffe, Lori Mayer, Toni Saldana-King, Colleen E Miller.   

Abstract

With the growing complexity of multiple sclerosis (MS) care, nursing professionals have increasing responsibility in managing clinical disease and treatment. Nursing professionals and other health care providers play important roles in educating patients about disease-modifying therapy options, the course of therapy, and managing potential adverse effects. A panel of nursing and MS experts was convened and used a modified Delphi method to reach consensus on best-practice recommendations for alemtuzumab infusion in MS patients. This valuable clinical resource provides a practical guide for clinicians to optimize patient education and implement strategies for infusion-associated reaction prophylaxis and management when administering alemtuzumab.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26295502     DOI: 10.1097/NAN.0000000000000127

Source DB:  PubMed          Journal:  J Infus Nurs        ISSN: 1533-1458


  4 in total

Review 1.  Alemtuzumab: A Review in Relapsing Remitting Multiple Sclerosis.

Authors:  Yahiya Y Syed
Journal:  Drugs       Date:  2020-12-24       Impact factor: 9.546

Review 2.  Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts.

Authors:  Thomas Berger; Irina Elovaara; Sten Fredrikson; Chris McGuigan; Lucia Moiola; Kjell-Morten Myhr; Celia Oreja-Guevara; Igor Stoliarov; Uwe K Zettl
Journal:  CNS Drugs       Date:  2017-01       Impact factor: 5.749

Review 3.  Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program.

Authors:  Eva Havrdova; Jeffrey A Cohen; Dana Horakova; Ivana Kovarova; Eva Meluzinova
Journal:  Ther Clin Risk Manag       Date:  2017-10-16       Impact factor: 2.423

4.  Alemtuzumab in Multiple Sclerosis: Lessons from Social Media in Enhancing Patient Care.

Authors:  Louise Rath; Nirosen Vijiaratnam; Olga Skibina
Journal:  Int J MS Care       Date:  2017 Nov-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.